MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 12.466
EU - Europa 10.375
AS - Asia 2.457
SA - Sud America 111
OC - Oceania 75
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 17
Totale 25.574
Nazione #
US - Stati Uniti d'America 12.275
IT - Italia 5.651
GB - Regno Unito 1.907
SE - Svezia 861
SG - Singapore 686
CN - Cina 677
DE - Germania 468
UA - Ucraina 334
FR - Francia 324
TR - Turchia 304
HK - Hong Kong 279
FI - Finlandia 255
BG - Bulgaria 153
JP - Giappone 135
CA - Canada 93
IE - Irlanda 91
IN - India 87
MX - Messico 77
AU - Australia 68
ID - Indonesia 67
NL - Olanda 53
RU - Federazione Russa 45
VN - Vietnam 39
PK - Pakistan 37
PL - Polonia 37
AR - Argentina 32
CH - Svizzera 30
TN - Tunisia 30
KR - Corea 29
LT - Lituania 29
BE - Belgio 27
BR - Brasile 27
MY - Malesia 27
IR - Iran 24
CL - Cile 21
ES - Italia 21
BZ - Belize 18
RO - Romania 17
EG - Egitto 16
EU - Europa 16
HU - Ungheria 14
PH - Filippine 13
SA - Arabia Saudita 13
CO - Colombia 11
PE - Perù 11
TW - Taiwan 11
AT - Austria 10
PT - Portogallo 10
ZA - Sudafrica 9
NZ - Nuova Zelanda 7
IL - Israele 6
JO - Giordania 6
LU - Lussemburgo 6
RS - Serbia 6
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
GR - Grecia 4
IQ - Iraq 4
NO - Norvegia 4
CZ - Repubblica Ceca 3
MA - Marocco 3
BD - Bangladesh 2
BO - Bolivia 2
GT - Guatemala 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
MM - Myanmar 1
MZ - Mozambico 1
SK - Slovacchia (Repubblica Slovacca) 1
VA - Santa Sede (Città del Vaticano) 1
Totale 25.574
Città #
Fairfield 1.722
Southend 1.515
Woodbridge 941
Chandler 917
Ashburn 884
Santa Clara 808
Houston 735
Wilmington 584
Seattle 579
Jacksonville 564
Singapore 562
Ann Arbor 531
Cambridge 530
Nyköping 513
Milan 406
Dearborn 387
Rome 352
Hong Kong 260
Modena 216
San Diego 179
Beijing 178
Izmir 175
Helsinki 168
New York 161
Sofia 149
Princeton 147
Redwood City 132
Eugene 113
Florence 96
London 87
Palermo 87
Bologna 84
Bari 82
Bremen 77
Falls Church 71
Naples 70
Catania 66
Dublin 60
Jakarta 60
Los Angeles 52
Shanghai 52
Genoa 49
Boardman 48
Tokyo 48
Des Moines 47
Turin 47
Perth 46
Padova 45
Verona 41
San Jose 40
Chicago 37
Frankfurt am Main 37
Cagliari 34
Dong Ket 30
Salerno 28
Parma 27
Guangzhou 26
Norwalk 26
Ottawa 26
Munich 25
Messina 24
Trento 23
Brescia 22
Reggio Emilia 22
Toronto 22
Bergamo 20
Livorno 20
Dallas 19
Napoli 19
Pescara 19
Belize City 18
Brussels 18
Monza 18
Pisa 18
Reggio Nell'emilia 18
Torino 18
Caserta 17
Hounslow 17
Nanjing 17
Atlanta 16
Council Bluffs 16
Mountain View 16
Mumbai 16
Treviso 16
Jinan 15
Paris 15
Kunming 14
Legnano 14
Mexico City 14
Phoenix 14
Reggio Calabria 14
Trieste 14
Venice 14
Amsterdam 13
Buenos Aires 13
Hefei 13
Perugia 13
Puebla City 13
São Paulo 13
Forlì 12
Totale 16.726
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.143
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.069
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 953
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 648
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 377
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 284
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 272
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 262
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 259
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 251
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 243
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 240
Current treatment of hepatitis C-associated rheumatic diseases. 232
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 228
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 228
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 219
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 218
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 217
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 215
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 210
Aortic pulse wave velocity measurement in systemic sclerosis patients. 208
Cardiac Involvement in Systemic Vasculitis 204
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 203
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 198
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 193
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 193
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 190
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 189
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 187
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 186
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 185
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 182
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 181
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 181
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 180
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 180
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 178
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 176
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 172
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 172
Scleroderma digital ulcers complicated by infection with fecal pathogens. 170
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 167
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 166
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 166
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 165
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 165
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 164
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 160
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 158
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 158
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 157
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 157
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 157
Procedural pain management in the treatment of scleroderma digital ulcers 156
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 155
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 154
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 153
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 152
Nailfold videocapillaroscopy in antisynthetase syndrome 152
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 151
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 150
Osteomyelitis complicating scleroderma digital ulcers. 149
Platelet gel in the treatment of severe scleroderma skin ulcers. 147
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 146
Cardiovascular risk and prostanoids in systemic sclerosis 143
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 143
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 143
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 143
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 142
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 142
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 140
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 139
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 139
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 139
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 139
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 139
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 139
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 138
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 137
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. 135
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 134
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 131
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 131
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 130
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 127
Mixed cryoglobulinemia syndrome: where are we going to? 126
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 125
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 125
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 123
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 122
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 121
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 120
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 118
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 117
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 117
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 116
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 116
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 113
Acute exacerbation of interstitial lung disease associated with rheumatic disease 112
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 111
Totale 21.956
Categoria #
all - tutte 108.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.040 0 0 0 0 340 630 540 503 430 201 217 179
2020/20214.266 333 128 297 365 448 404 370 550 297 458 306 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.236 221 274 279 454 574 346 355 548 151 240 342 452
2024/20252.345 332 195 231 581 1.006 0 0 0 0 0 0 0
Totale 26.005